You are currently on the new version of our website. Access the old version .

20 Results Found

  • Article
  • Open Access
12 Citations
4,018 Views
18 Pages

Radiation-Induced Bystander Effect: Loss of Radioprotective Capacity of Rosmarinic Acid In Vivo and In Vitro

  • Amparo Olivares,
  • Miguel Alcaraz-Saura,
  • Daniel Gyingiri Achel,
  • Juan de Dios Berná-Mestre and
  • Miguel Alcaraz

3 February 2021

In radiation oncology, the modulation of the bystander effect is a target both for the destruction of tumor cells and to protect healthy cells. With this objective, we determine whether the radioprotective capacity of rosmarinic acid (RA) can affect...

  • Article
  • Open Access
4 Citations
2,871 Views
13 Pages

Growth and Migration Blocking Effect of Nanaomycin K, a Compound Produced by Streptomyces sp., on Prostate Cancer Cell Lines In Vitro and In Vivo

  • Yuto Hirata,
  • Katsumi Shigemura,
  • Michika Moriwaki,
  • Masato Iwatsuki,
  • Yuki Kan,
  • Tooru Ooya,
  • Koki Maeda,
  • Youngmin Yang,
  • Takuji Nakashima and
  • Masato Fujisawa
  • + 2 authors

10 May 2023

Since castration-resistant prostate cancer (CRPC) acquires resistance to molecularly targeted drugs, discovering a class of drugs with different mechanisms of action is needed for more efficient treatment. In this study, we investigated the anti-tumo...

  • Article
  • Open Access
2,066 Views
11 Pages

An Antibody of the Secreted Isoform of Disintegrin and Metalloprotease 9 (sADAM9) Inhibits Epithelial–Mesenchymal Transition and Migration of Prostate Cancer Cell Lines

  • Yura Jotatsu,
  • Shain-Ying Sung,
  • Ming-Heng Wu,
  • Shunya Takeda,
  • Yuto Hirata,
  • Koki Maeda,
  • Shiuh-Bin Fang,
  • Kuan-Chou Chen and
  • Katsumi Shigemura

Prostate cancer (PC) is the most common cancer diagnosed in men worldwide. Currently, castration-resistant prostate cancer (CRPC), which is resistant to androgen deprivation therapy, has a poor prognosis and is a therapeutic problem. We investigated...

  • Article
  • Open Access
5 Citations
3,104 Views
17 Pages

MINDIN Exerts Protumorigenic Actions on Primary Prostate Tumors via Downregulation of the Scaffold Protein NHERF-1

  • Luis Álvarez-Carrión,
  • Irene Gutiérrez-Rojas,
  • María Rosario Rodríguez-Ramos,
  • Juan A. Ardura and
  • Verónica Alonso

24 January 2021

Advanced prostate cancer preferential metastasis to bone is associated with osteomimicry. MINDIN is a secreted matrix protein upregulated in prostate tumors that overexpresses bone-related genes during prostate cancer progression. Na+/H+ exchanger re...

  • Article
  • Open Access
18 Citations
5,577 Views
14 Pages

Targeting Fat Oxidation in Mouse Prostate Cancer Decreases Tumor Growth and Stimulates Anti-Cancer Immunity

  • Amanda Guth,
  • Emily Monk,
  • Rajesh Agarwal,
  • Bryan C. Bergman,
  • Karin A. Zemski-Berry,
  • Angela Minic,
  • Kimberly Jordan and
  • Isabel R. Schlaepfer

18 December 2020

Lipid catabolism represents an Achilles heel in prostate cancer (PCa) that can be exploited for therapy. CPT1A regulates the entry of fatty acids into the mitochondria for beta-oxidation and its inhibition has been shown to decrease PCa growth. In th...

  • Article
  • Open Access
33 Citations
9,068 Views
17 Pages

Prevention of Prostate Cancer with Oleanane Synthetic Triterpenoid CDDO-Me in the TRAMP Mouse Model of Prostate Cancer

  • Xiaohua Gao,
  • Dorrah Deeb,
  • Yongbo Liu,
  • Ali S. Arbab,
  • George W. Divine,
  • Scott A. Dulchavsky and
  • Subhash C. Gautam

19 August 2011

2-Cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid (CDDO), a synthetic analog of oleanolic acid, and its C28 methyl ester derivative (CDDO-Me), have shown potent antitumorigenic activity against a wide range of cancer cell lines, including prostate ca...

  • Article
  • Open Access
17 Citations
5,543 Views
14 Pages

Trpm8 Expression in Human and Mouse Castration Resistant Prostate Adenocarcinoma Paves the Way for the Preclinical Development of TRPM8-Based Targeted Therapies

  • Sacha Genovesi,
  • Riccardo Moro,
  • Beatrice Vignoli,
  • Dario De Felice,
  • Marco Canossa,
  • Rodolfo Montironi,
  • Francesco Giuseppe Carbone,
  • Mattia Barbareschi,
  • Andrea Lunardi and
  • Alessandro Alaimo

23 January 2022

Metastatic prostate cancer (mPCa) is one of the leading causes of cancer-related mortality in both the US and Europe. Androgen deprivation is the first-line therapy for mPCa; however, resistance to therapy inevitably occurs and the disease progresses...

  • Article
  • Open Access
7 Citations
2,878 Views
10 Pages

Combined Treatment with Ultrasound and Immune Checkpoint Inhibitors for Prostate Cancer

  • Fuuka Hayashi,
  • Katsumi Shigemura,
  • Koki Maeda,
  • Aya Hiraoka,
  • Noriaki Maeshige,
  • Tooru Ooya,
  • Shian-Ying Sung,
  • Yong-Ming Yang and
  • Masato Fujisawa

27 April 2022

Background: Ultrasound (US) is mostly used for diagnostic purpose but could be used for cancer treatments with a US intensity or frequency fitted to such a purpose. Prostate cancer (PC) has the highest prevalence in the urological field, but indicati...

  • Article
  • Open Access
15 Citations
6,217 Views
13 Pages

Zinc Inhibits Expression of Androgen Receptor to Suppress Growth of Prostate Cancer Cells

  • Phuong Kim To,
  • Manh-Hung Do,
  • Young-Suk Cho,
  • Se-Young Kwon,
  • Min Soo Kim and
  • Chaeyong Jung

8 October 2018

The prostate gland contains a high level of intracellular zinc, which is dramatically diminished during prostate cancer (PCa) development. Owing to the unclear role of zinc in this process, therapeutic applications using zinc are limited. This study...

  • Article
  • Open Access
15 Citations
3,873 Views
13 Pages

Background: Inflammation is known to promote tumor formation and progression; however, we found a natural anti-inflammatory factor, interleukin (IL)-1 receptor antagonist (IL1RN), in a mouse transgenic adenocarcinoma of the mouse prostate (TRAMP)-C1-...

  • Article
  • Open Access
2,261 Views
18 Pages

Combined Therapy Targeting MET and Pro-HGF Activation Shows Significant Therapeutic Effect Against Liver Metastasis of CRPC

  • Shoichi Kimura,
  • Satoshi Iwano,
  • Takahiro Akioka,
  • Takahiro Kuchimaru,
  • Makiko Kawaguchi,
  • Tsuyoshi Fukushima,
  • Yuichiro Sato,
  • Hiroaki Kataoka,
  • Toshiyuki Kamoto and
  • Atsuro Sawada
  • + 1 author

The liver is the most lethal metastatic site in castration-resistant prostate cancer (CRPC). Overexpression of MET protein has been reported in CRPC, and MET is an important driver gene in androgen-independent CRPC cells. Mouse CRPC cell line CRTC2 w...

  • Communication
  • Open Access
1 Citations
2,032 Views
15 Pages

Performance of Imidazoquinoline Glycoconjugate BAIT628 as a TLR7 Agonist Prodrug for Prostate Cancer

  • Seyedeh A. Najibi,
  • S. M. Al Muied Pranto,
  • Muhammad Haroon,
  • Amy E. Nielsen and
  • Rock J. Mancini

Despite broad anti-cancer efficacy as Toll-Like Receptor (TLR) 7/8 agonists, imidazoquinolines remain limited in use via systemic administration or in situ vaccination therapies due to inflammatory toxicity. One approach to address this challenge inv...

  • Article
  • Open Access
4 Citations
2,606 Views
15 Pages

The β-Secretase 1 Enzyme as a Novel Therapeutic Target for Prostate Cancer

  • Hilal A. Rather,
  • Sameh Almousa,
  • Ashish Kumar,
  • Mitu Sharma,
  • Isabel Pennington,
  • Susy Kim,
  • Yixin Su,
  • Yangen He,
  • Abdollah R. Ghara and
  • Gagan Deep
  • + 3 authors

19 December 2023

Recent studies have demonstrated the association of APP and Aβ with cancer, suggesting that BACE1 may play an important role in carcinogenesis. In the present study, we assessed BACE1’s usefulness as a therapeutic target in prostate cancer...

  • Article
  • Open Access
8 Citations
4,264 Views
12 Pages

31 March 2020

Background: Several lines of evidence have demonstrated the tumor-promoting function of inflammation. Since many chemokines are important in coordinating immune cells during inflammation, monitoring intratumoral chemokines provides a way to study the...

  • Article
  • Open Access
39 Citations
10,677 Views
23 Pages

9 April 2015

To examine the effects of high-fat diet (HFD) containing lard on prostate cancer development and progression and its underlying mechanisms, transgenic adenocarcinoma mouse prostate (TRAMP) and TRAMP-C2 allograft models, as well as in vitro culture mo...

  • Article
  • Open Access
1,853 Views
20 Pages

Potentiating Salvage Radiotherapy in Radiorecurrent Prostate Cancer Through Anti-CTLA4 Therapy: Implications from a Syngeneic Model

  • Hanzhi Wang,
  • Linsey Gong,
  • Xiaoyong Huang,
  • Stephanie D. White,
  • Hans T. Chung,
  • Danny Vesprini,
  • Tera N. Petchiny,
  • Emmanouil Fokas,
  • Hansen He and
  • Stanley K. Liu
  • + 1 author

14 August 2024

High-risk prostate cancer (PCa) is a leading cause in cancer death and can elicit significant morbidity and mortality. Currently, the salvage of local disease recurrence after radiation therapy (RT) is a major clinical problem. Immune checkpoint inhi...

  • Article
  • Open Access
26 Citations
7,870 Views
13 Pages

Benzyl Isothiocyanate Inhibits Prostate Cancer Development in the Transgenic Adenocarcinoma Mouse Prostate (TRAMP) Model, Which Is Associated with the Induction of Cell Cycle G1 Arrest

  • Han Jin Cho,
  • Do Young Lim,
  • Gyoo Taik Kwon,
  • Ji Hee Kim,
  • Zunnan Huang,
  • Hyerim Song,
  • Yoon Sin Oh,
  • Young-Hee Kang,
  • Ki Won Lee and
  • Jung Han Yoon Park
  • + 1 author

22 February 2016

Benzyl isothiocyanate (BITC) is a hydrolysis product of glucotropaeolin, a compound found in cruciferous vegetables, and has been shown to have anti-tumor properties. In the present study, we investigated whether BITC inhibits the development of pros...

  • Article
  • Open Access
13 Citations
4,820 Views
14 Pages

Restraining Akt1 Phosphorylation Attenuates the Repair of Radiation-Induced DNA Double-Strand Breaks and Reduces the Survival of Irradiated Cancer Cells

  • Klaudia Szymonowicz,
  • Sebastian Oeck,
  • Adam Krysztofiak,
  • Jansje Van der Linden,
  • George Iliakis and
  • Verena Jendrossek

The survival kinase protein kinase B (Akt) participates in the regulation of essential subcellular processes, e.g., proliferation, growth, survival, and apoptosis, and has a documented role in promoting resistance against genotoxic stress including r...

  • Article
  • Open Access
4 Citations
3,830 Views
27 Pages

A Mutated Prostatic Acid Phosphatase (PAP) Peptide-Based Vaccine Induces PAP-Specific CD8+ T Cells with Ex Vivo Cytotoxic Capacities in HHDII/DR1 Transgenic Mice

  • Pauline Le Vu,
  • Jayakumar Vadakekolathu,
  • Sarra Idri,
  • Holly Nicholls,
  • Manon Cavaignac,
  • Stephen Reeder,
  • Masood A. Khan,
  • Dennis Christensen,
  • Alan Graham Pockley and
  • Stéphanie E. McArdle

13 April 2022

Background: Current treatments for castrate (hormone)-resistant prostate cancer (CRPC) remain limited and are not curative, with a median survival from diagnosis of 23 months. The PAP-specific Sipuleucel-T vaccine, which was approved by the FDA in 20...

  • Article
  • Open Access
15 Citations
5,240 Views
16 Pages

Fusion Protein Vaccine Based on Ag85B and STEAP1 Induces a Protective Immune Response against Prostate Cancer

  • Linpei Guo,
  • Hui Xie,
  • Zheng Zhang,
  • Zhun Wang,
  • Shuanghe Peng,
  • Yuanjie Niu and
  • Zhiqun Shang

(1) Background: There are currently limited treatments for castration-resistant prostate cancer. Immunotherapy involving Sipuleucel-T has increasingly drawn attention for prostate cancer management. BCG plays a vital role in treating bladder cancer,...